Phase II Study of Postoperative Adjuvant Immunotherapy and Radiation in Patients With Completely Resected Stage II and Stage IIIA Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2009
At a glance
- Drugs Anti-idiotype cancer vaccine Titan Pharmaceuticals (Primary) ; Anti-idiotype CEA antibody vaccine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 11 Aug 2006 Status change
- 24 Sep 2005 New trial record.